Last updated on March 2018

A clinical research study of Darbepoetin alfa, Iron Therapy, Placebo, Daprodustat

Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Contact Investigators or Research Sites near you

Start Over

US GSK Clinical Trials Call ...

GSK Investigational Site
Roseburg, OR United States
  Connect »